Download PDF
Aktuelle Dermatologie 2017; 43(08/09): 357-360
DOI: 10.1055/s-0043-116933
Kasuistik
© Georg Thieme Verlag KG Stuttgart · New York

Leishmaniasis auf Mallorca: Vorstellung eines ungewöhnlichen Verlaufs unter Immunsuppression

Leishmaniasis on the Island of Majorca: A Presentation of an Unusual Case under Immunosuppression
M. Gebhardt
Abteilung Dermatologie, Venerologie und Allergologie, Tropendermatologie, Bundeswehrkrankenhaus Hamburg
,
M. Ostermann
Abteilung Dermatologie, Venerologie und Allergologie, Tropendermatologie, Bundeswehrkrankenhaus Hamburg
,
M. Fischer
Abteilung Dermatologie, Venerologie und Allergologie, Tropendermatologie, Bundeswehrkrankenhaus Hamburg
› Author Affiliations
Further Information

Publication History

Publication Date:
31 August 2017 (online)

Also available at
   Permissions and Reprints

Zusammenfassung

Das spanische Festland und die Balearen sind Endemiegebiete für die kutane und viszerale Leishmaniasis durch Leishmania infantum. Die kutane Leishmaniasis ist die häufigste Verlaufsform.

Der Hauptvektor, die Sandmücke Phlebotomus perniciosus, ist im gesamten Inselgebiet von Mallorca zu finden. Die Leishmaniasis zeichnet sich durch eine Vielzahl von klinischen Erscheinungsbildern aus. Der Immunstatus des Patienten spielt hierbei eine relevante Rolle für den Verlauf der Erkrankung und das Ansprechen der Therapie.

Abstract

The Spanish mainland and the Balearic Islands are endemic regions for cutaneous und visceral leishmaniasis caused by leishmania infantum. Cutaneous leishmaniasis is most frequently seen.

The main vector is the sandfly Phlebotomus perniciosus which is distributed on the whole island of Mallorca. Leishmaniasis can present with a variety of clinical pictures. Additionally immunosuppression plays an important role for further progress and for the search of an appropriate treatment.

 

  • Literatur

  • 1 Carillo E, Moreno J, Cruz I. What is responsible for a large and unusual outbreak of leishmaniasis in Madrid?. Trends Parasitol 2013; 29: 579-580
    CrossrefPubMedGoogle Scholar
  • 2 Desjeux P, Alwar J. Leishmania/HIV co-infections: epidemiology in Europe. Ann Trop Med Parasitol 2003; 97 (Suppl. 01) 3-15
    CrossrefPubMedGoogle Scholar
  • 3 Van Griensven J, Carillo E, López-Vélez R. et al. Leishmaniasis in immunosuppressed individuals. Clin Microbiol Infect 2014; 20: 286-299
    CrossrefPubMedGoogle Scholar
  • 4 Marcoval J, Penín RM. Evolution of cutaneous leishmaniasis in the last 30 years in a tertiary hospital of the European Mediterranean coast. Int j Dermatol 2017; [Epub ahead of print] DOI: 10.1111/ijd.13588.
    CrossrefPubMedGoogle Scholar
  • 5 Tomson N, Symonds RP, Moir AA. et al. New World leishmaniasis from Spain. Postgrad Med J 2002; 78: 757-758
    CrossrefPubMedGoogle Scholar
  • 6 Alcover MM, Ballart C, Martín-Sánchez J. et al. Factors influencing the presence of sand flies in Majorca (Balearic Island, Spain) with special reference to Phlebotomus pernicious, vector of Leishmania infantum. Parasit Vectors 2014; 7: 421
    CrossrefPubMedGoogle Scholar
  • 7 Millán J, Zanet S, Gomis M. et al. An investigation into alternative reservoirs of canine leishmaniasis on the endemic island of Mallorca (Spain). Transbound Emerg Dis 2011; 58: 352-357
    CrossrefPubMedGoogle Scholar
  • 8 Solano-Gallego L, Morell P, Arboix M. et al. Prevalence of Leishmania infantum Infection in Dogs Living in an Area of Canine Leishmaniasis Endemicity Using PCR on Several Tissues an Serology. J Clin Microbiol 2001; 39: 560-563
    CrossrefPubMedGoogle Scholar
  • 9 Von Stebut E. Leishmaniasis. J Dtsch Dermatol Ges 2015; 13: 191-201
    CrossrefPubMedGoogle Scholar
  • 10 Goto H, Lauletta Lindoso JA. Cutaneous and mucocutaneous leishmaniasis. Infect Dis Clin North Am 2012; 26: 293-307
    CrossrefPubMedGoogle Scholar
  • 11 Boecken G, Sunderkötter C, Bogdan C. et al. Diagnosis and therapy of cutaneous and mucocutaneous Leishmaniasis in Germany. J Dtsch Dermatol Ges 2011; 9 (Suppl. 08) 1-51
    PubMedGoogle Scholar